About this journal
As an internationally recognized journal, Molecular Cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention, diagnostics, and treatment. Ranked in the top 25% in the Oncology category of Journal Citation Reports, the journal receives over 70,000 article accesses a month. The journal prides itself on less than 7 days time-to-first-decision, welcoming submissions of broad interest including: target therapies; molecular and cellular biology; genomics; genetics and epigenetics; pathology and tumor immunology. Molecular Cancer is the definitive journal for researchers and clinicians in the field of molecular oncology.
